A new Springboard for Translational Research and Education


Improving outcomes for patients through research-informed healthcare is at the heart of the St Vincent’s Darlinghurst Research Precinct. Impressive achievements have been enabled and supported by both Government and philanthropic funding.

The Precinct already comprises a workforce of 1,560 researchers and medical specialists with Australia’s closest clinician-researcher collaborations currently working in a co-ordinated manner across the Garvan Institute of Medical Research, Victor Chang Cardiac Research Institute (VCCRI) and St Vincent’s Centre for Applied Medical Research (AMR).

A new St Vincent’s Translational Research and Education Centre is to be established to provide additional research facilities for the ground-breaking work of the VCCRI, new St Vincent’s Centres of Excellence in Cellular Therapy and Neurosciences, as well as for teaching and education.

The Centre will drive translational research Australia-wide, through a strategic alignment with the NSW State Government’s Action Plan: Accelerating Research and Development in NSW and the Federal Government’s objectives and strategic platforms within the Medical Research Fund’s current Medical Research and Innovation Strategy. It will position St Vincent’s Health Precinct for future growth and improved healthcare outcomes for all.

As with current activities of St Vincent’s Health Precinct, the new Centre will support job creation in the medical and innovative medical sectors, driving patient and commercial outcomes for the community and wider Australia.

To realise the vision of the new Centre, $200 million investment is being sought through Government funding, private investment and philanthropy, with NSW Treasurer Matt Keane MP and Federal Member for Wentworth Hon Dave Sharma MP assisting St Vincent’s.

Getting the latest medical treatments and cures from the lab bench to patients as rapidly as possible is a key focus of the Government’s medical research strategy. The new St Vincent’s Translational Research Centre will enable St Vincent’s to expand their already outstanding clinical trials and research in Cardiovascular Medicine, Cellular Therapy and Neurosciences to benefit our community,” Mr Sharma said.

St Vincent’s Curran Foundation and VCCRF have committed to raising $50 million for this visionary project.

Planning for the Centre to be located on Liverpool St, adjacent to the Lowy Packer Building, The Kinghorn Cancer Centre and the Garvan Institute of Medical Research.

The Centre will house important facilities including:
• Victor Chang Cardiac Research Institute’s Advanced Translational Research Facility (ATF)
• St Vincent’s Clinical Trials Hub and Infusion Centre
• Cellular Therapy Centre of Excellence
• Education and Applied Learning Centre
• Infectious Diseases and Immunology Research Hub
• Virtual and Digital Health Research Hub
• Future co-location of industry partners to boost rapid commercialisation

We look forward to sharing more about this important new project in the coming months.